What draws me to this research is the possibility of another option for someone who wants help. That is very different from promising a simple answer to addiction.
Clinical trials are investigating semaglutide — the active ingredient in Ozempic — for alcohol use disorder. In a 2026 trial involving people with obesity and alcohol use disorder, heavy-drinking days fell more with semaglutide than with placebo. Both groups also received cognitive behavioural therapy, a form of talking treatment.
The support matters too
This is encouraging research in a particular group of people. It does not show that peptides treat every addiction, or that a medicine can replace recovery support.
I want Her Own Way to make room for the person behind the result: their circumstances, the help they have and what they want life to look like. Treatment decisions need a clinician who understands substance use and their wider health.
If you may be alcohol-dependent, please get medical advice before stopping suddenly. Withdrawal can be dangerous. You do not have to work that out on your own.